Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 2,793 shares at $9.18 ($26K) on 2022-10-13, disclosed to the SEC on 2022-10-17.
Open-market sale of $26k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |